Iroko Cardio International Chooses Veeva CRM for European-wide Deployment
(
reducing the incidence of major adverse cardiac events (MACE), has adopted
Veeva CRM to support all of its representatives in nine European countries.
Both field and office-based users have begun to leverage the advanced
functionality of the new system to manage their customer information and
interactions, citing quick deployment, ease of use, cost efficiency, and
scalability as key benefits thus far.
“I’ve lived through several CRM implementations before, and the ‘sell’ to
end users was never easy,” confided
customer operations at Iroko. “I’m pleased to say that the feedback on
Veeva’s system has been very positive. Users appreciate the well-designed
interface, the features we’ve added to the standard version, and the quick
screen refresh times.”
Veeva’s Professional Services team worked closely with
deploy the Veeva CRM system to all users in only six weeks. Time to market
was a major advantage over traditional client/server CRM systems, which
typically require a minimum of three to six months to deploy.
“As a small, but pan-European company, we weren’t able to embark on a
lengthy requirements definition, configuration, and implementation exercise,”
explained Guenther. “With Veeva, we were spared that; we experienced a very
fast, user-oriented design phase for changes to the basic system, often with
immediate response on design requests. And by relying on the Veeva
Professional Services team to help us load data and create reports for the
first three months of operation, we had an extraordinarily easy transition.”
Veeva Systems has rapidly become the leading provider of Pharma CRM
solutions globally. As a multi-tenant SaaS application built in the cloud,
Veeva CRM requires no hardware or software to purchase, scale, or maintain.
In addition, all Veeva customers benefit from free, automatic upgrades so
users are always on the most up-to-date version of the software and benefit
from the very latest compliance changes and system enhancements. Changes can
be made to the system instantly, without user retraining or additional
third-party costs.
“By designing Veeva CRM to fit the specific requirements of the European
pharmaceutical industry, we have enabled companies like
deploy quickly and painlessly,” said
Europe. “And our truly multi-tenant technology platform anchors a solution
that our customers will never outgrow.”
“The fact that Veeva’s solution is cloud-based and therefore easy on our
IT infrastructure was very compelling,” added Guenther. “Plus, we can add
promising new features later on, without undergoing massive development
projects.”
About
regional distribution partners, Iroko produces and promotes
Aggrastat/Agrastat(R) worldwide with the exception of the
regions it serves.
About Veeva Systems
Veeva Systems is the leader in cloud-based solutions for the global life
sciences industry. Committed to innovation, product excellence, and customer
success, Veeva has over 80 customers, ranging from the world’s largest
pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is a
privately-held company headquartered in the
offices in
information, visit http://www.veevasystems.com.
Copyright (c) 2011 Veeva Systems. All rights reserved. Veeva and the
Veeva logo are registered trademarks of Veeva Systems. Veeva Systems owns
other registered and unregistered trademarks. Other names used herein may be
trademarks of their respective owners.
Media Contact
Selma Nawaz
European Marketing Director
Veeva Systems
selma.nawaz@veevasystems.com
SOURCE Veeva Systems
